PT  - JOURNAL ARTICLE
AU  - Paul, Elise
AU  - Kounali, Daphne
AU  - Kwong, Alex S. F.
AU  - Smith, Daniel
AU  - Costantini, Ilaria
AU  - Lawlor, Deborah A.
AU  - Sayal, Kapil
AU  - Bould, Helen
AU  - Timpson, Nicholas J.
AU  - Northstone, Kate
AU  - Lewcock, Melanie
AU  - Tilling, Kate
AU  - Pearson, Rebecca M.
TI  - Trajectories of child emotional and behavioural difficulties before and during the COVID-19 pandemic in a longitudinal UK cohort
AID  - 10.1101/2021.05.11.21257040
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.11.21257040
4099  - http://medrxiv.org/content/early/2021/05/13/2021.05.11.21257040.short
4100  - http://medrxiv.org/content/early/2021/05/13/2021.05.11.21257040.full
AB  - Importance COVID-19 public health mitigation measures are likely to have detrimental effects on emotional and behavioural problems in children. However, longitudinal studies with pre-pandemic data are scarce.Objective To explore trajectories of children’s emotional and behavioural difficulties during the COVID-19 pandemic.Design and setting Data were from children from the third generation of a birth cohort study; the Avon Longitudinal Study of Parents and Children - Generation 2 (ALSPAC-G2) in the southwest of England.Participants The study population comprised of 708 children (median age at COVID-19 data collection was 4.4 years, SD=2.9, IQR= [2.2 to 6.9]), whose parents provided previous pre-pandemic surveys and a survey between 26 May and 5 July 2020 that focused on information about the COVID-19 pandemic as restrictions from the first lockdown in the UK were eased.Exposures We employed multi-level mixed effects modelling with random intercepts and slopes to examine whether children’s trajectories of emotional and behavioural difficulties (a combined total difficulties score) during the pandemic differ from expected pre-pandemic trajectories.Main outcomes Children had up to seven measurements of emotional and behavioural difficulties from infancy to late childhood, using developmentally appropriate scales such as the Emotionality Activity Sociability Temperament Survey in infancy and Strengths and Difficulties Questionnaire in childhood.Results The observed normative pattern of children’s emotional and behavioural difficulties pre-pandemic, was characterised by an increase in scores during infancy peaking around the age of 2, and then declining throughout the rest of childhood. Pre-pandemic, the decline in difficulties scores after age 2 was 0.6 points per month; but was approximately one third of that in post-pandemic trajectories (there was a difference in mean rate of decline after age 2 of 0.2 points per month in pre vs during pandemic trajectories [95 % CI: 0.10 to 0.30, p <0.001]). This lower decline in scores over the years translated to older children having pandemic difficulty scores higher than would be expected from pre-pandemic trajectories (for example, an estimated 10.0 point (equivalent of 0.8 standard deviations) higher score (95% CI: 5.0 to 15.0) by age 8.5 years). Results remained similar although somewhat attenuated after adjusting for maternal anxiety and age.Conclusion and relevance The COVID-19 pandemic may be associated with greater persistence of emotional and behavioural difficulties after the age 2. Emotional difficulties in childhood predict later mental health problems. Further evidence and monitoring of emotional and behavioural difficulties are required to fully understand the potential role of the pandemic on young children.Question How has the COVID-19 pandemic influenced emotional difficulties in young children?Findings Using repeated longitudinal data from before and during the pandemic we provide evidence that emotional difficulty scores of primary school aged children are higher by an estimated 10.0 points (0.8 standard deviations) (95% CI: 5.0 to 15.0) by age 8.5 years than would be expected based on pre pandemic data.Meaning The level of difference in emotional difficulties found in the current study has been linked to increased likelihood of mental health problems in adolescence and adulthood. Therefore, this increase in difficulties needs careful monitoring and support.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the UK Medical Research Council and Wellcome (Grants 217065/Z/19/Z and 102215), the European Research Commission grants (Grant Ref: 758813 MHINT and 669545 DevelopObese), the Elizabeth Blackwell Institute, University of Bristol, which is funded by the Quality-Related Strategic Priorities Fund, UK Research and Innovation and the University of Bristol. ASFK, DS, DAL, NJT, KT, and RMP work in or are affiliated with a Unit that is supported by the University of Bristol and the UK Medical Research Council (MC_UU_00011/1-3 and MC_UU_00011/1-6) and DAL, KT AND RMP work in the UK National Institute of Health Research (NIHR) Biomedical Research Centre which is funded by the University of Bristol and NIHR. DAL is a NIHR Senior Investigator (NF-0616-10102). A comprehensive list of grants that have supported data collection in ALSPAC since it first started is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the ALSPAC Law and Ethics Committee and the Local Research Ethics Committees and written informed consent was provided.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe study website contains details of all data available through a fully searchable data dictionary (http://www.bristol.ac.uk/alspac/researchers/our-data/).